Navigation Links
Introgen Reports Promising Phase 1/2 Clinical Results With INGN 241,in Patients With Advanced Solid Tumors

SEATTLE--(BUSINESS WIRE)--Jun 1, 2007 - Introgen Therapeutics, Inc. (NASDAQ:INGN) reported promising Phase 1/2 clinical data with INGN 241, the Company's novel investigational mda-7/IL-24 tumor suppressor agent, in patients with advanced solid tumors.

The data (Abstract #380), which were presented today at the annual meeting of the American Society of Gene Therapy, showed that in this 22-patient trial, INGN 241 induced killing in all treated tumors, including in those patients who failed prior therapy with other anti-cancer agents. INGN 241 was well tolerated, and a maximum tolerated dose was not reached. Tumor growth control was observed in 44 percent of treated tumors. Two of five patients treated at the highest dose showed objective responses (greater than 50 percent reduction in tumor size). Increases in the number of immune cells known to mediate anti-tumor effects were also observed in all patients, consistent with the immune-stimulating activity of INGN 241.

Although INGN 241 was administered directly to tumors, evidence of distant biologic activity was observed, suggesting that this therapy may have utility in treating primary tumors as well as metastatic disease. INGN 241 treatment in combination with radiotherapy is being evaluated in an ongoing Phase 3 trial in solid tumors, including patients with head and neck cancer.

"These data are particularly encouraging because they demonstrate INGN 241 has clinical activity even in patients who have failed previous therapies," said Sunil Chada, Ph.D., associate vice president, Clinical Research and Development at Introgen.

INGN 241 Shown to Restore Platinum Sensitivity in Preclinical Studies

Data from preclinical studies of INGN 241 also were presented (Abstract #197) that evaluated the ability of INGN 241 to restore cisplatin sensitivity to ovarian cancer cells that are cisplatin-resistant. The results showed that INGN 241 effecti
'"/>




Page: 1 2 3

Related medicine technology :

1. Introgen Reports Updated Phase 2 Advexin Data Correlating Improved Survival, Tumor Responses and Predictive p53 Biomarker
2. Introgens Advexin Demonstrates Clinical Benefit in Inherited Cancer
3. Introgen and Clinical Collaborators to Report New Results with Advanced-Stage Cancer Therapies at Upcoming Medical Meetings
4. Preclinical Studies Identify Novel Approach for Enhancing the Anticancer Activity of Introgens INGN 241
5. Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference
6. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
7. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
10. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
11. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
Post Your Comments:
(Date:9/17/2014)... , Sept. 17, 2014 Germany Gynecological ... GlobalData,s new report, "Germany Gynecological Devices Market ... the Germany Gynecological Devices market. The report provides ... units) and average prices (in US dollars) within ... Devices (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips ...
(Date:9/17/2014)... NEW YORK , Sept. 17, 2014 ... of PDL BioPharma, Inc. ("PDL BioPharma" or the "Company") ... Robert S. Willoughby at rswilloughby@pomlaw.com or ... PDL BioPharma and certain of its officers and/or directors ... Exchange Act of 1934.  On September ...
(Date:9/17/2014)... 17, 2014 Bronstein, Gewirtz & Grossman, LLC ... the securities of PDL BioPharma, Inc. ("PDL BioPharma" or ... investors are advised to contact Peretz Bronstein ... at info@bgandg.com or 212-697-6484. The ... its executives violated federal securities laws. On ...
Breaking Medicine Technology:Germany Gynecological Devices Market Outlook to 2020 2Germany Gynecological Devices Market Outlook to 2020 3SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PDL BioPharma, Inc. - PDLI 2Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Investigates claims on behalf of Investors of PDL BioPharma, Inc. --PDLI 2
(Date:9/18/2014)... September 18, 2014 For many people, tomato ... an online food delivery service provider, gives it a new ... Tomato Basil soup is a nod to this culinary classic—with ... a tangy tomato base, then Spoonful of Comfort's chefs stir ... A flashback to childhood has never tasted better. , ...
(Date:9/18/2014)... Computer Resources of America, Inc. (CRA), ... York City, has been awarded a contract to provide ... with stores in over 150 countries. The services will ... being the retailer’s dispatch arm handling all IT support ... Chief Executive Officer of CRA said, “We are excited ...
(Date:9/18/2014)... Albany, NY (PRWEB) September 18, 2014 ... foods, which have special functions of adjusting human ... etc., have won great popularity with a variety ... of health food in China reached RMB187.4 billion, ... of 22.1% during 2006-2013. , View Full Report ...
(Date:9/18/2014)... Boston, MA (PRWEB) September 18, 2014 ... train its team and surgeon partners in Less ... to joining SpineFrontier, Tamara authored an extensive education ... holds a Masters in Science in Organizational Leadership, ... multiple industries for eleven years. Bringing her to ...
(Date:9/18/2014)... September 18, 2014 Dr. Suzaunna Clark, ... 1- sometimes, inner beauty has to be seen to ... be acknowledged in order to be used. Together, both ... shows the world how to do both. ... Coaching using the Healing Hearts system, which provides professional ...
Breaking Medicine News(10 mins):Health News:An Old Classic Brings New Soup Delivery Options to Spoonful of Comfort 2Health News:CRA Awarded Managed Support Contract for Global Retailer 2Health News:China Health Food Industry Size 2014 Market Analysis, Growth, Trends and Forecast Report 2017: MarketResearchReports.biz 2Health News:China Health Food Industry Size 2014 Market Analysis, Growth, Trends and Forecast Report 2017: MarketResearchReports.biz 3Health News:China Health Food Industry Size 2014 Market Analysis, Growth, Trends and Forecast Report 2017: MarketResearchReports.biz 4Health News:SpineFrontier Inc. Makes Bold Move to Expand Its Internal Training Team to Collaborate With The LESSociety’s Less Exposure Surgery® University To Educate Surgeons. 2Health News:Suzaunna-Where Life! Happens Announces the Launch of Healing Hearts 2Health News:Suzaunna-Where Life! Happens Announces the Launch of Healing Hearts 3
... seek answers to questions of motivation and self-actualization. "Make ... Honaman employs lessons learned in his career working with ... to help others direct their energies and develop their ... "Make It Happen" that personal branding is the process ...
... 20 Hooper Holmes, Inc. (Amex: HH ... Health and Wellness Division, Christopher J. Behling, will be ... Colloquium on Tuesday, March 3, 2009 at 9:00 a.m. ... Regency at Penn,s Landing in Philadelphia, Pennsylvania. Mr. Behling,s ...
... Faced with news of increasing layoffs, straining economic times, ... hiring is based on looks, millions of American women ... them a competitive edge in the workplace. In a ... of 18 and 64 compiled by the ASPS, many ...
... 20 The Niwano Peace Foundation announced Friday it will ... Baguma Byamugisha, an Anglican priest of Uganda, in recognition of ... people living with HIV/AIDS.An award presentation ceremony will take place ... award certificate, Rev. Byamugisha will receive a medal and 20 ...
... York, NY, February 20, 2009 Although widespread Prostate-Specific-Antigen ... there a point of diminishing returns? In a study ... Journal of Urology , researchers found that in a ... years old or older and had a PSA below ...
... in chronic obstructive lung disease (COPD) themselves increase ... days of full, asymptomatic recoverybad news for patients ... progression of the disease. , "This concept ... for the analysis of clinical trial data and ...
Cached Medicine News:Health News:Business Strategist Applies Corporate Experience to Self-Help: 'Make It Happen' 2Health News:Hooper Holmes to Present at the Ninth Population Health and Disease Management Colloquium 2Health News:Hooper Holmes to Present at the Ninth Population Health and Disease Management Colloquium 3Health News:In Today's Economy, Women In The Workforce Link Cosmetic Chicago Plastic Surgery To Success 2Health News:In Today's Economy, Women In The Workforce Link Cosmetic Chicago Plastic Surgery To Success 3Health News:Rev. Byamugisha of Uganda to Receive Niwano Peace Prize 2Health News:When should prostate-specific antigen testing be stopped? 2Health News:Exacerbations in COPD: One thing leads to another 2Health News:Exacerbations in COPD: One thing leads to another 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: